clioquinol has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cole, GM | 1 |
| Andersen, JK; Beal, MF; Boonplueang, R; Bush, AI; Cherny, RA; DiMonte, D; Ellerby, L; Jacobs, R; Kaur, D; Kumar, J; Mo, JQ; Rajagopalan, S; Viswanath, V; Volitaskis, I; Yang, L; Yantiri, F | 1 |
| Cheng, A; Huang, C; Liu, W; Luo, Q; Shi, L; Shi, R; Xia, Y; Zeng, W; Zhengli, C | 1 |
3 other study(ies) available for clioquinol and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
| Article | Year |
|---|---|
Ironic fate: can a banned drug control metal heavies in neurodegenerative diseases?
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Animals; Clioquinol; Ferritins; Gene Expression; Humans; Iron; Iron Chelating Agents; Legislation, Drug; Mice; Mice, Transgenic; Neurodegenerative Diseases; Oxidation-Reduction; Parkinson Disease; Substantia Nigra | 2003 |
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: a novel therapy for Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Blotting, Western; Cell Death; Clioquinol; Dopamine; Ferritins; Gene Expression; Genetic Therapy; Homovanillic Acid; Humans; Immunohistochemistry; Iron; Iron Chelating Agents; Mice; Mice, Transgenic; Oxidative Stress; Parkinson Disease; Parkinson Disease, Secondary; Promoter Regions, Genetic; Rats; Substantia Nigra; Tyrosine 3-Monooxygenase | 2003 |
Clioquinol improves motor and non-motor deficits in MPTP-induced monkey model of Parkinson's disease through AKT/mTOR pathway.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Clioquinol; Disease Models, Animal; Haplorhini; Motor Activity; Parkinson Disease; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2020 |